Preferences and Experiences Regarding the Use of the Self-Sampling Device in hrHPV Screening for Cervical Cancer.
Journal
The patient
ISSN: 1178-1661
Titre abrégé: Patient
Pays: New Zealand
ID NLM: 101309314
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
accepted:
07
09
2021
pubmed:
25
9
2021
medline:
17
3
2022
entrez:
24
9
2021
Statut:
ppublish
Résumé
To improve participation in the Dutch cervical cancer screening, a self-sampling device (SSD) was introduced in 2017 into the Dutch population-based screening programme (PBS) for the early detection of cervical cancer. The aim of this study was to gather potential preferences and experiences that might influence a woman's decision to use the SSD in the Dutch PBS. A scoping review was performed in the PubMed database. Studies that assessed preferences and experiences of women regarding the SSD were included, and preferences and experiences were extracted. In addition, in a qualitative study, the list of potential preferences and experiences specific for the Dutch PBS was extended based on semi-structured interviews with SSD users as well as non-SSD users who recently participated in the PBS, analysed in a structured manner by translating full sentences to key words. Ninety-eight studies were included in the scoping review and 16 interviews were performed. Frequently mentioned reasons for using the SSD, in both the interviews and the literature, were practicality and comfort. Frequently mentioned reasons for not using the SSD were fear of not performing the SSD procedure correctly and doubts on whether the results of the high-risk human papillomavirus (hrHPV) test will be reliable. A new positive experience elicited in the interviews was accessibility. Negative preferences and experiences were not being aware the SSD was an option, and the inconvenience that after an hrHPV-positive test result of the SSD, an additional smear test at the GP is necessary. Several preferences and experiences play a role in the choice whether or not to use the SSD. Based on the currently found preferences and experiences, an app will be developed in order to assess which of these are the most important for women participating in the Dutch population-based cervical screening programme.
Sections du résumé
BACKGROUND
To improve participation in the Dutch cervical cancer screening, a self-sampling device (SSD) was introduced in 2017 into the Dutch population-based screening programme (PBS) for the early detection of cervical cancer. The aim of this study was to gather potential preferences and experiences that might influence a woman's decision to use the SSD in the Dutch PBS.
METHODS
A scoping review was performed in the PubMed database. Studies that assessed preferences and experiences of women regarding the SSD were included, and preferences and experiences were extracted. In addition, in a qualitative study, the list of potential preferences and experiences specific for the Dutch PBS was extended based on semi-structured interviews with SSD users as well as non-SSD users who recently participated in the PBS, analysed in a structured manner by translating full sentences to key words.
RESULTS
Ninety-eight studies were included in the scoping review and 16 interviews were performed. Frequently mentioned reasons for using the SSD, in both the interviews and the literature, were practicality and comfort. Frequently mentioned reasons for not using the SSD were fear of not performing the SSD procedure correctly and doubts on whether the results of the high-risk human papillomavirus (hrHPV) test will be reliable. A new positive experience elicited in the interviews was accessibility. Negative preferences and experiences were not being aware the SSD was an option, and the inconvenience that after an hrHPV-positive test result of the SSD, an additional smear test at the GP is necessary.
CONCLUSION
Several preferences and experiences play a role in the choice whether or not to use the SSD. Based on the currently found preferences and experiences, an app will be developed in order to assess which of these are the most important for women participating in the Dutch population-based cervical screening programme.
Identifiants
pubmed: 34558035
doi: 10.1007/s40271-021-00550-y
pii: 10.1007/s40271-021-00550-y
pmc: PMC8866331
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
245-253Informations de copyright
© 2021. The Author(s).
Références
Asian Pac J Cancer Prev. 2014;15(17):7437-41
pubmed: 25227855
Eur J Cancer. 2009 Oct;45(15):2640-8
pubmed: 19695864
Clinics (Sao Paulo). 2017 Mar;72(3):183-187
pubmed: 28355365
Prev Med. 2019 Aug;125:5-11
pubmed: 31054907
J Cancer Educ. 2021 Feb;36(1):126-133
pubmed: 31522376
BMC Public Health. 2019 Jan 17;19(1):80
pubmed: 30654774
Gynecol Oncol. 2014 Dec;135(3):487-94
pubmed: 25284037
BMC Med. 2019 Dec 11;17(1):228
pubmed: 31829241
J Med Screen. 2016 Sep;23(3):164-70
pubmed: 26919866
BMC Public Health. 2019 Jul 18;19(1):963
pubmed: 31319838
Sex Transm Infect. 2017 Feb;93(1):56-61
pubmed: 28100761
Eur J Gen Pract. 2018 Dec;24(1):9-18
pubmed: 29199486
Prev Med. 2014 Jul;64:108-13
pubmed: 24736093
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
BMC Public Health. 2014 Jun 12;14:596
pubmed: 24927941
Lancet. 2004 Jul 17-23;364(9430):249-56
pubmed: 15262102
BMJ. 2013 Jan 28;346:f167
pubmed: 23358487
J Obstet Gynaecol. 2012 Jan;32(1):87-91
pubmed: 22185546
J Low Genit Tract Dis. 2003 Apr;7(2):107-16
pubmed: 17051055
Womens Health Issues. 2014 Sep-Oct;24(5):511-8
pubmed: 25213744
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Low Genit Tract Dis. 2018 Oct;22(4):302-310
pubmed: 30179994
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583